Preclinical studies with GDNF [29, 56, 57], neurturin [58], or BDNF as reported and shown in this study have allowed gaining insight into the potential benefits of gene therapy to restore the DA innervation in PD. The gene discussed is BDNF; the disease is Parkinson disease.